| 1 |
28614905 | Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU). | 2017 Oct |
1 |
| 2 |
20660823 | Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. | 2010 Aug 20 |
1 |
| 3 |
15944291 | Enhanced expression of CD20 in human tumor B cells is controlled through ERK-dependent mechanisms. | 2005 Jun 15 |
1 |
| 4 |
10707790 | Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens. | 2000 |
1 |